ag-1549 has been researched along with Acquired Immune Deficiency Syndrome in 3 studies
capravirine: a non-nucleoside reverse transcriptase inhibitor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mowbray, CE | 2 |
| Burt, C | 1 |
| Corbau, R | 2 |
| Gayton, S | 1 |
| Hawes, M | 1 |
| Perros, M | 2 |
| Tran, I | 1 |
| Price, DA | 1 |
| Quinton, FJ | 1 |
| Selby, MD | 1 |
| Stupple, PA | 1 |
| Webster, R | 2 |
| Wood, A | 1 |
| Jones, LH | 1 |
| Allan, G | 1 |
| Hay, D | 1 |
| Middleton, DS | 1 |
| Newman, SD | 1 |
| Randall, A | 1 |
| Vuong, H | 1 |
| Westby, M | 1 |
| Williams, D | 1 |
| Gallant, JE | 1 |
3 other studies available for ag-1549 and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Pyrazole NNRTIs 4: selection of UK-453,061 (lersivirine) as a development candidate.
Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-HIV Agents; Cell Line; Drug Resistance, Viral; HIV | 2009 |
Optimization of 5-aryloxyimidazole non-nucleoside reverse transcriptase inhibitors.
Topics: Acquired Immunodeficiency Syndrome; Allosteric Site; Antiviral Agents; Cell Line; Chemistry, Pharmac | 2008 |
New antiretroviral agents.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; | 2001 |